Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Heart failure and Cardiology, with related work in Intensive care medicine, Meta-analysis, Cardiogenic shock. Notable publications include 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials', 'Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF', and 'Management of Acute Decompensated Valvular Heart Disease'.
Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)
Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis—a narrative review: a joint session with the Romanian Society of Cardiology (part II)
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial
Heart Failure Outcomes and Empagliflozin Effects in Patients with Heart Failure and Reduced Ejection Fraction in Sinus Rhythm or Atrial Fibrillation: Data from EMPEROR-Reduced
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Management of Acute Decompensated Valvular Heart Disease